Biosenic (STU:BT1) Price-to-Operating-Cash-Flow : (As of May. 26, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biosenic Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Biosenic's share price is €0.0218. Biosenic's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.03. Hence, Biosenic's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Biosenic's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:BT1's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Biosenic's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 75.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 36.80% per year.

During the past 10 years, Biosenic's highest 3-Year average Operating Cash Flow per Share Growth Rate was 75.50% per year. The lowest was -112.10% per year. And the median was 1.70% per year.

Biosenic Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biosenic's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Price-to-Operating-Cash-Flow Chart

Biosenic Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Biosenic Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biosenic's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Biosenic's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biosenic's Price-to-Operating-Cash-Flow falls into.

Biosenic Price-to-Operating-Cash-Flow Calculation

Biosenic's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0218	/	-0.03
	=

Biosenic's Share Price of today is €0.0218.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biosenic's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.03.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Biosenic Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biosenic's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic (STU:BT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (STU:BT1) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BT1:Germany BIOS:Belgium

Address

Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435

Website

https://www.biosenic.com

Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (STU:BT1) Headlines

No Headlines